What does Taisho do?
TAISHO is a company that specializes in the development and manufacturing of pharmaceutical products and healthcare solutions. It focuses on innovative research to enhance health and improve quality of life. With a commitment to sustainability, TAISHO aims to deliver effective products that meet the needs of patients and healthcare providers.
- Sectors
- Real estate agencies
- Signals
-
Poor liquidityPoor liquidity 0.84
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 24KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.33MStrong equity provides a buffer against setbacks.
Low riskLow risk 45.0%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 177KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 207KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 11.2%Social debts stay manageable relative to personnel costs.
- Shareholders
- 3.13 99,94%
- Investments
- Contrast 94,98%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
274K
|
€
210K
|
€
255K
|
€
191K
|
|
|
€
207K
|
€
153K
|
€
233K
|
€
173K
|
|
|
€
-6K
|
€
-115
|
€
108K
|
€
51K
|
|
|
€
1.33M
|
€
1.35M
|
€
1.36M
|
€
1.33M
|
|
|
45.01%
|
44.61%
|
37.10%
|
47.82%
|
|
|
€
1.47M
|
€
1.51M
|
€
2.14M
|
€
1.27M
|
|
|
€
147
|
€
1K
|
€
13K
|
€
83K
|
|
|
0.70
|
0.70
|
|
|
Publications 33
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Doel - Ontslagen - Benoemingen 20/06/2023
- Ontslagen - Benoemingen 11/07/2017
- Boekjaar 20/01/2017
- Me. - Jaarrekening 31.12.2015, Ggk 13.06.2016, Ngl 20.09.2016 16605-0369-016 28/09/2016
- Me. - Jaarrekening 31.12.2014, Ggk 08.06.2015, Ngl 30.06.2015 15258-0501-016 07/07/2015
Frequently asked questions
Answers to the most common questions about Taisho, based on official government data and the filed annual accounts.
What is the VAT number of Taisho?
The VAT number of Taisho is BE0453.772.136.
How many employees work at Taisho?
In 2025, Taisho employed 0.70 full-time equivalents (FTE).
When was Taisho established?
Taisho was founded in 08-11-1994.
What is the official address of Taisho?
The official address of Taisho is Scheldestraat 13 Antwerpen 2000.
What is the legal form of Taisho?
The juridical form of Taisho is Public limited company (NV/SA).
What is the annual revenue of Taisho?
The 2025 accounts of Taisho do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Taisho do?
TAISHO is a company that specializes in the development and manufacturing of pharmaceutical products and healthcare solutions. It focuses on innovative research to enhance health and improve quality of life. With a commitment to sustainability, TAISHO aims to deliver effective products that meet the needs of patients and healthcare providers.
Is Taisho a reliable company?
Taisho is a registered Rechtspersoon with company number 0453.772.136 and can be verified through the official CBE database.
What is the credit limit of Taisho?
The estimated credit limit of Taisho is €227,890.
Is Taisho still active?
Taisho currently has the status "Normal situation" and is active.